SARCOMA CONNECT has summarised the highlights from the recent ESMO Sarcoma and GIST 2020 meeting for you.

Dr Jonathan C. Trent earned his MD and PhD in cancer biology from The University of Texas Health Science Center where he also completed a residency in internal medicine. He then completed a fellowship in medical oncology at The University of Texas M. D. Anderson Cancer Center while serving as chief fellow. Prior to joining the University of Miami, Sylvester Comprehensive Cancer Center, he held an appointment as associate professor of medicine in the Department of Sarcoma Medical Oncology, Division of Cancer Medicine at the University of Texas M. D. Anderson Cancer Center in Houston. Dr Trent is currently the Associate Director for Clinical Research, the Director of the Bone and Soft-tissue Sarcoma Group and Medical Director of the Precision Medicine Initiative at the Sylvester Comprehensive Cancer Center. Dr Trent’s interests are in the clinical and translational research of sarcomas, direct care of sarcoma patients, and education about sarcoma. As Associate Director for Clinical Research, his goal is to help Sylvester Faculty develop clinical trials that provide clinically effective and scientifically exciting therapy to cancer patients of South Florida and beyond. The major focus of his clinical, educational and research efforts are with gastrointestinal stromal tumor (GIST), chondrosarcoma, and other sarcomas. The major efforts of Dr Trent’s research focus on understanding the mechanisms of action and resistance of imatinib in GIST and other sarcomas while striving toward improved therapeutic options. His work involves the use of novel preoperative/postoperative clinical trials, prospectively acquired tumor tissue, cell lines, archival tissue, as well as collaborations with disciplines such as the genomics facility, surgical oncology, pathology, radiology and interventional radiology.

Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
SARCOMA CONNECT

SARCOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Karyopharm Therapeutics.

Meet the experts Independent IME approved

Other programmes of interest

podcast Video podcast
Oncology 
Highlights from CTOS 2022

Experts
Prof. Jonathan Trent, Prof. Robin Jones
  • download Downloadable
    Resources
  • clock 22 MIN
  • calendar Jan 2023
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer
Oncology 
Publication Snapshot: Regorafenib for the Treatment of Sarcoma

Video snapshot, slide set and infographic available

Experts
Prof. Robert Maki
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2022
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer
podcast Video podcast
Oncology 
Clinical implications of guidelines in Sarcoma

Experts
Prof. Robert Maki, Prof. Silvia Stacchiotti
  • download Downloadable
    Resources
  • clock 28 MIN
  • calendar Aug 2022
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer
Oncology 
Update from ASCO 2022 – Sarcoma

SARCOMA update by Prof. Jonathan Trent, University of Miami Hospital, USA

Experts
Prof. Jonathan Trent
  • clock 2 MIN
  • calendar Jun 2022
  • Non-accredited Independent Medical Education

e-learning Interactive e-learning
Oncology Bone diseases 
Diagnosis and Management of Bone Sarcoma

Experts
Prof. Silvia Stacchiotti, Prof. Florence Duffaud
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar Mar 2022
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Bayer
conference-update Conference update

Episode

4

of 4

episode
Oncology 
Highlights from ESMO 2026

Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers

Experts
Dr Elizabeth Smyth, Dr Yelena Janjigian, Assoc. Prof. Gerald Prager, Prof. Hong Jae Chon, Assoc. Prof. Lorenza Rimassa, Dr Tom Newsom-Davis, Dr Louise Lim, Dr Komal Jhaveri, Dr Roberto Iacovelli
Endorsed by
  • download Downloadable
    Resources
  • clock 9 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education